CELINA CARRUTH: Open Payments
NPI 1942284120 · DEMOREST, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$224 in 11 payments from 8 companies in 2025. Trend: 2023 $458 · 2024 $250 · 2025 $224
Food & beverage: $224
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $81 |
| PFIZER INC. | 1 | $27 |
| Eisai Inc. | 1 | $27 |
| GlaxoSmithKline, LLC. | 1 | $21 |
| ABBVIE INC. | 1 | $19 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $19 |
| Merck Sharp & Dohme LLC | 1 | $16 |
| Xeris Pharmaceuticals, Inc. | 1 | $14 |
Products named: Wegovy, ELIQUIS, Leqembi, SHINGRIX, VRAYLAR, JARDIANCE, Rybelsus, GARDASIL 9.
Industry payments across GA — which companies pay providers there.
